Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 77

Results For "president"

1680 News Found

USFDA approves intramuscular administration for Merck’s MMRV family of vaccines
Drug Approval | March 07, 2023

USFDA approves intramuscular administration for Merck’s MMRV family of vaccines

With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly


Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey
News | March 07, 2023

Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey

These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.


Aptar appoints Julie Xing to its Board of Directors
People | March 07, 2023

Aptar appoints Julie Xing to its Board of Directors

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.


Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
News | March 04, 2023

Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments

The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients


ProBioGen’s growth strategy continues successfully
News | March 03, 2023

ProBioGen’s growth strategy continues successfully

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team


AstraZeneca expands its portfolio by bringing rare disease therapy for patients in India
News | March 01, 2023

AstraZeneca expands its portfolio by bringing rare disease therapy for patients in India

Receives regulatory approval for its molecule ‘Selumetinib’ in India


Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi
Drug Approval | February 28, 2023

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region


Agilent announces cell analysis workflow automation for immuno-oncology, virology, and vaccine development markets
Digitisation | February 27, 2023

Agilent announces cell analysis workflow automation for immuno-oncology, virology, and vaccine development markets

New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator


EMA recommends refusal of the marketing authorization for Lagevrio
News | February 25, 2023

EMA recommends refusal of the marketing authorization for Lagevrio

Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.


MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates
Diagnostic Center | February 24, 2023

MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates

Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months